Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |